Key facts
- Naviday Health’s last known valuation is $16.0M (May 2023).
- It has raised $3.8M; the latest was Accelerator/Incubator in Jul 2025.
- Notable investors include Techstars, MassChallenge, Right Side Capital Management, Village Capital, Founder Institute — 10 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for Naviday Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Naviday Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Naviday Health
Developer of a cloud-based digital healthcare platform intended to address various encounters important to proper therapeutic care. The company's platform identifies providers with outreach to patients for new drug innovations, it schedules, monitors, and provides information and feedback on drug usage of prescription and over-the-counter medicines for consumers and designated medical contacts, enabling physicians and healthcare professionals to mitigate risks regarding the selection of treatment and therapies.
- Sector
- Healthcare
- HQ
- Boston, MA, United States
- Founded
- 2019
- Employees
- 10
- Website
- navidayhealth.com/
- Ownership
- Privately Held (backing)
Naviday Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Naviday Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Naviday Health in its N-PORT filings yet. We sweep new filings monthly.